Pro-dopaminergic pharmacological interventions for anhedonia in depression: a living systematic review and network meta-analysis of human and animal studies. Article Swipe
YOU?
·
· 2025
· Open Access
·
· DOI: https://doi.org/10.48620/92289
Background It is unclear whether pro-dopaminergic drugs reduce anhedonia in major depressive disorder (MDD) and further, if so, to what extent this is the case.Methods With lived experienced experts we co-produced two living systematic reviews of randomised controlled trials (RCTs) investigating the relative efficacy of pro-dopaminergic interventions in reducing symptoms of anhedonia in people with MDD (versus placebo) and in relevant non-human animal models (versus vehicle control/no intervention). Multiple electronic databases were searched until June 9, 2024. The primary outcomes were subjective anhedonia symptoms in humans and sucrose preference test (a measure of reward sensitivity and proxy for anhedonia) in animals. We evaluated other important domains and clinical aspects closely related to anhedonia, such as reward/reinforcement tasks, anxiety symptoms, acceptability, tolerability, and adverse events. We performed pairwise meta-analyses separately for human and non-human studies. We also estimated the relative effects of pro-dopaminergic versus non-dopaminergic antidepressants in human studies on anhedonia and overall depressive symptoms using a series of random-effects network meta-analyses of both aggregate and patient-level data. A multidisciplinary panel of international experts (including people with lived experience) then interpreted the overall results and produced a list of recommendations via a triangulation process. This study is part of GALENOS (Global Alliance for Living Evidence in aNxiety, depressiOn, and pSychosis). PROSPERO registration: CRD42023451821.Findings Pro-dopaminergic interventions were associated with a small reduction of anhedonia symptoms (6 RCTs, n = 2076; SMD -0.24, 95% CI -0.46 to -0.03) in people with MDD and increased sucrose preference in animal models (27 RCTs; SMD 1.34, 0.88 to 1.79). We did not find data about reward/reinforcement tasks in humans. Evidence was rated as low to moderate. In the network meta-analysis, some antidepressants with a non-dopaminergic mechanism of action showed reduction in anhedonia symptoms, which was larger than pro-dopaminergic drugs and probably independent of overall depression improvement.Interpretation Our findings provide some support for the role of dopamine in anhedonia. However, the precise neurobiological mechanisms of anhedonia in major depression are still poorly understood and we posit that they may be possibly related to altogether different or more general effects of antidepressants on these symptoms. Therefore, data on reward, including reward-related learning and memory, are needed to properly examine the relationship between dopamine modulation and anhedonia.Funding Wellcome (GALENOS project).
Related Topics
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.48620/92289
- OA Status
- green
- OpenAlex ID
- https://openalex.org/W7104659049
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W7104659049Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.48620/92289Digital Object Identifier
- Title
-
Pro-dopaminergic pharmacological interventions for anhedonia in depression: a living systematic review and network meta-analysis of human and animal studies.Work title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2025Year of publication
- Publication date
-
2025-10-29Full publication date if available
- Authors
-
Ostinelli, Edoardo G, Salanti, Georgia, Macleod Malcolm, Chiocchia, Virginia, Smith, Katharine A, Stringaris, Argyris, Downs, James, Robinson, Emma Sj, Malhi Gin S, Dwyer, Dominic M, Chevance Astrid, Correll, Christoph U., Tonia, Thomai, Wheeler, Emily, Furukawa, Toshi A., Pizzagalli, Diego A., Browning, Michael, Potts, Jennifer, Cipriani AndreaList of authors in order
- Landing page
-
https://doi.org/10.48620/92289Publisher landing page
- Open access
-
YesWhether a free full text is available
- OA status
-
greenOpen access status per OpenAlex
- OA URL
-
https://doi.org/10.48620/92289Direct OA link when available
- Concepts
-
Anhedonia, Psychological intervention, Clinical psychology, Medicine, Psychiatry, Anxiety, Major depressive disorder, Psychology, Randomized controlled trial, Systematic review, Clinical Global Impression, Clinical trial, Placebo, Mood, Pairwise comparison, PsycINFO, Quality of life (healthcare), Human studies, Depression (economics), Psilocybin, Novelty, Adverse effect, Rating scaleTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
0Total citation count in OpenAlex
Full payload
| id | https://openalex.org/W7104659049 |
|---|---|
| doi | https://doi.org/10.48620/92289 |
| ids.doi | https://doi.org/10.48620/92289 |
| ids.openalex | https://openalex.org/W7104659049 |
| fwci | 0.0 |
| type | article |
| title | Pro-dopaminergic pharmacological interventions for anhedonia in depression: a living systematic review and network meta-analysis of human and animal studies. |
| biblio.issue | |
| biblio.volume | |
| biblio.last_page | |
| biblio.first_page | |
| topics[0].id | https://openalex.org/T11071 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 0.20255331695079803 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2736 |
| topics[0].subfield.display_name | Pharmacology |
| topics[0].display_name | Treatment of Major Depression |
| topics[1].id | https://openalex.org/T10853 |
| topics[1].field.id | https://openalex.org/fields/32 |
| topics[1].field.display_name | Psychology |
| topics[1].score | 0.1590450406074524 |
| topics[1].domain.id | https://openalex.org/domains/2 |
| topics[1].domain.display_name | Social Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/3205 |
| topics[1].subfield.display_name | Experimental and Cognitive Psychology |
| topics[1].display_name | Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes |
| topics[2].id | https://openalex.org/T13283 |
| topics[2].field.id | https://openalex.org/fields/32 |
| topics[2].field.display_name | Psychology |
| topics[2].score | 0.10759465396404266 |
| topics[2].domain.id | https://openalex.org/domains/2 |
| topics[2].domain.display_name | Social Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/3205 |
| topics[2].subfield.display_name | Experimental and Cognitive Psychology |
| topics[2].display_name | Mental Health Research Topics |
| is_xpac | False |
| apc_list | |
| apc_paid | |
| concepts[0].id | https://openalex.org/C2778941446 |
| concepts[0].level | 3 |
| concepts[0].score | 0.9520601630210876 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q545365 |
| concepts[0].display_name | Anhedonia |
| concepts[1].id | https://openalex.org/C27415008 |
| concepts[1].level | 2 |
| concepts[1].score | 0.5653200745582581 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q7256382 |
| concepts[1].display_name | Psychological intervention |
| concepts[2].id | https://openalex.org/C70410870 |
| concepts[2].level | 1 |
| concepts[2].score | 0.549731433391571 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q199906 |
| concepts[2].display_name | Clinical psychology |
| concepts[3].id | https://openalex.org/C71924100 |
| concepts[3].level | 0 |
| concepts[3].score | 0.49449098110198975 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[3].display_name | Medicine |
| concepts[4].id | https://openalex.org/C118552586 |
| concepts[4].level | 1 |
| concepts[4].score | 0.4671802520751953 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q7867 |
| concepts[4].display_name | Psychiatry |
| concepts[5].id | https://openalex.org/C558461103 |
| concepts[5].level | 2 |
| concepts[5].score | 0.4419552683830261 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q154430 |
| concepts[5].display_name | Anxiety |
| concepts[6].id | https://openalex.org/C2780051608 |
| concepts[6].level | 3 |
| concepts[6].score | 0.4354924261569977 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q42844 |
| concepts[6].display_name | Major depressive disorder |
| concepts[7].id | https://openalex.org/C15744967 |
| concepts[7].level | 0 |
| concepts[7].score | 0.4119352400302887 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q9418 |
| concepts[7].display_name | Psychology |
| concepts[8].id | https://openalex.org/C168563851 |
| concepts[8].level | 2 |
| concepts[8].score | 0.4097388982772827 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q1436668 |
| concepts[8].display_name | Randomized controlled trial |
| concepts[9].id | https://openalex.org/C189708586 |
| concepts[9].level | 3 |
| concepts[9].score | 0.3745622932910919 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q1504425 |
| concepts[9].display_name | Systematic review |
| concepts[10].id | https://openalex.org/C2776000289 |
| concepts[10].level | 4 |
| concepts[10].score | 0.3513312041759491 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q5133761 |
| concepts[10].display_name | Clinical Global Impression |
| concepts[11].id | https://openalex.org/C535046627 |
| concepts[11].level | 2 |
| concepts[11].score | 0.3399415910243988 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q30612 |
| concepts[11].display_name | Clinical trial |
| concepts[12].id | https://openalex.org/C27081682 |
| concepts[12].level | 3 |
| concepts[12].score | 0.31797218322753906 |
| concepts[12].wikidata | https://www.wikidata.org/wiki/Q269829 |
| concepts[12].display_name | Placebo |
| concepts[13].id | https://openalex.org/C2780733359 |
| concepts[13].level | 2 |
| concepts[13].score | 0.316914439201355 |
| concepts[13].wikidata | https://www.wikidata.org/wiki/Q331769 |
| concepts[13].display_name | Mood |
| concepts[14].id | https://openalex.org/C184898388 |
| concepts[14].level | 2 |
| concepts[14].score | 0.3059503138065338 |
| concepts[14].wikidata | https://www.wikidata.org/wiki/Q1435712 |
| concepts[14].display_name | Pairwise comparison |
| concepts[15].id | https://openalex.org/C2779549880 |
| concepts[15].level | 3 |
| concepts[15].score | 0.27237558364868164 |
| concepts[15].wikidata | https://www.wikidata.org/wiki/Q5542226 |
| concepts[15].display_name | PsycINFO |
| concepts[16].id | https://openalex.org/C2779951463 |
| concepts[16].level | 2 |
| concepts[16].score | 0.2705414593219757 |
| concepts[16].wikidata | https://www.wikidata.org/wiki/Q7268788 |
| concepts[16].display_name | Quality of life (healthcare) |
| concepts[17].id | https://openalex.org/C3018263421 |
| concepts[17].level | 2 |
| concepts[17].score | 0.2688371241092682 |
| concepts[17].wikidata | https://www.wikidata.org/wiki/Q80083 |
| concepts[17].display_name | Human studies |
| concepts[18].id | https://openalex.org/C2776867660 |
| concepts[18].level | 2 |
| concepts[18].score | 0.2653004825115204 |
| concepts[18].wikidata | https://www.wikidata.org/wiki/Q1814941 |
| concepts[18].display_name | Depression (economics) |
| concepts[19].id | https://openalex.org/C2776502132 |
| concepts[19].level | 3 |
| concepts[19].score | 0.2630937397480011 |
| concepts[19].wikidata | https://www.wikidata.org/wiki/Q208118 |
| concepts[19].display_name | Psilocybin |
| concepts[20].id | https://openalex.org/C2778738651 |
| concepts[20].level | 2 |
| concepts[20].score | 0.2600536644458771 |
| concepts[20].wikidata | https://www.wikidata.org/wiki/Q16546687 |
| concepts[20].display_name | Novelty |
| concepts[21].id | https://openalex.org/C197934379 |
| concepts[21].level | 2 |
| concepts[21].score | 0.2552982270717621 |
| concepts[21].wikidata | https://www.wikidata.org/wiki/Q2047938 |
| concepts[21].display_name | Adverse effect |
| concepts[22].id | https://openalex.org/C83849319 |
| concepts[22].level | 2 |
| concepts[22].score | 0.2538471817970276 |
| concepts[22].wikidata | https://www.wikidata.org/wiki/Q7295720 |
| concepts[22].display_name | Rating scale |
| keywords[0].id | https://openalex.org/keywords/anhedonia |
| keywords[0].score | 0.9520601630210876 |
| keywords[0].display_name | Anhedonia |
| keywords[1].id | https://openalex.org/keywords/psychological-intervention |
| keywords[1].score | 0.5653200745582581 |
| keywords[1].display_name | Psychological intervention |
| keywords[2].id | https://openalex.org/keywords/anxiety |
| keywords[2].score | 0.4419552683830261 |
| keywords[2].display_name | Anxiety |
| keywords[3].id | https://openalex.org/keywords/major-depressive-disorder |
| keywords[3].score | 0.4354924261569977 |
| keywords[3].display_name | Major depressive disorder |
| keywords[4].id | https://openalex.org/keywords/randomized-controlled-trial |
| keywords[4].score | 0.4097388982772827 |
| keywords[4].display_name | Randomized controlled trial |
| keywords[5].id | https://openalex.org/keywords/systematic-review |
| keywords[5].score | 0.3745622932910919 |
| keywords[5].display_name | Systematic review |
| keywords[6].id | https://openalex.org/keywords/clinical-global-impression |
| keywords[6].score | 0.3513312041759491 |
| keywords[6].display_name | Clinical Global Impression |
| keywords[7].id | https://openalex.org/keywords/clinical-trial |
| keywords[7].score | 0.3399415910243988 |
| keywords[7].display_name | Clinical trial |
| language | en |
| locations[0].id | doi:10.48620/92289 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S7407053152 |
| locations[0].source.type | repository |
| locations[0].source.is_oa | False |
| locations[0].source.issn_l | |
| locations[0].source.is_core | False |
| locations[0].source.is_in_doaj | False |
| locations[0].source.display_name | Open Access CRIS of the University of Bern |
| locations[0].source.host_organization | |
| locations[0].source.host_organization_name | |
| locations[0].source.host_organization_lineage | |
| locations[0].license | |
| locations[0].pdf_url | |
| locations[0].version | |
| locations[0].raw_type | article-journal |
| locations[0].license_id | |
| locations[0].is_accepted | False |
| locations[0].is_published | |
| locations[0].raw_source_name | |
| locations[0].landing_page_url | https://doi.org/10.48620/92289 |
| indexed_in | datacite |
| authorships[0].author.id | |
| authorships[0].author.orcid | |
| authorships[0].author.display_name | Ostinelli, Edoardo G |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Ostinelli, Edoardo G |
| authorships[0].is_corresponding | True |
| authorships[1].author.id | https://openalex.org/A2197042182 |
| authorships[1].author.orcid | |
| authorships[1].author.display_name | Salanti, Georgia |
| authorships[1].countries | DE |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I4210150406 |
| authorships[1].affiliations[0].raw_affiliation_string | Institut für Sozial- und Präventivmedizin (ISPM) - Evidence Synthesis Methods |
| authorships[1].institutions[0].id | https://openalex.org/I4210150406 |
| authorships[1].institutions[0].ror | https://ror.org/https://ror.org/04bhvak10 |
| authorships[1].institutions[0].type | nonprofit |
| authorships[1].institutions[0].lineage | https://openalex.org/I4210150406 |
| authorships[1].institutions[0].country_code | DE |
| authorships[1].institutions[0].display_name | Institut für Soziale Arbeit |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Salanti, Georgia |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Institut für Sozial- und Präventivmedizin (ISPM) - Evidence Synthesis Methods |
| authorships[2].author.id | https://openalex.org/A2436554467 |
| authorships[2].author.orcid | |
| authorships[2].author.display_name | Macleod Malcolm |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Macleod, Malcolm |
| authorships[2].is_corresponding | False |
| authorships[3].author.id | |
| authorships[3].author.orcid | |
| authorships[3].author.display_name | Chiocchia, Virginia |
| authorships[3].countries | DE |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I4210150406 |
| authorships[3].affiliations[0].raw_affiliation_string | Institut für Sozial- und Präventivmedizin (ISPM) - Evidence Synthesis Methods |
| authorships[3].institutions[0].id | https://openalex.org/I4210150406 |
| authorships[3].institutions[0].ror | https://ror.org/https://ror.org/04bhvak10 |
| authorships[3].institutions[0].type | nonprofit |
| authorships[3].institutions[0].lineage | https://openalex.org/I4210150406 |
| authorships[3].institutions[0].country_code | DE |
| authorships[3].institutions[0].display_name | Institut für Soziale Arbeit |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Chiocchia, Virginia |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Institut für Sozial- und Präventivmedizin (ISPM) - Evidence Synthesis Methods |
| authorships[4].author.id | |
| authorships[4].author.orcid | |
| authorships[4].author.display_name | Smith, Katharine A |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Smith, Katharine A |
| authorships[4].is_corresponding | False |
| authorships[5].author.id | https://openalex.org/A4299935116 |
| authorships[5].author.orcid | |
| authorships[5].author.display_name | Stringaris, Argyris |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Stringaris, Argyris |
| authorships[5].is_corresponding | False |
| authorships[6].author.id | |
| authorships[6].author.orcid | |
| authorships[6].author.display_name | Downs, James |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | Downs, James |
| authorships[6].is_corresponding | False |
| authorships[7].author.id | |
| authorships[7].author.orcid | |
| authorships[7].author.display_name | Robinson, Emma Sj |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | Robinson, Emma Sj |
| authorships[7].is_corresponding | False |
| authorships[8].author.id | https://openalex.org/A3200923045 |
| authorships[8].author.orcid | |
| authorships[8].author.display_name | Malhi Gin S |
| authorships[8].author_position | middle |
| authorships[8].raw_author_name | Malhi, Gin S |
| authorships[8].is_corresponding | False |
| authorships[9].author.id | |
| authorships[9].author.orcid | |
| authorships[9].author.display_name | Dwyer, Dominic M |
| authorships[9].author_position | middle |
| authorships[9].raw_author_name | Dwyer, Dominic M |
| authorships[9].is_corresponding | False |
| authorships[10].author.id | https://openalex.org/A4287486779 |
| authorships[10].author.orcid | |
| authorships[10].author.display_name | Chevance Astrid |
| authorships[10].author_position | middle |
| authorships[10].raw_author_name | Chevance, Astrid |
| authorships[10].is_corresponding | False |
| authorships[11].author.id | https://openalex.org/A2742914646 |
| authorships[11].author.orcid | |
| authorships[11].author.display_name | Correll, Christoph U. |
| authorships[11].author_position | middle |
| authorships[11].raw_author_name | Correll, Christoph U |
| authorships[11].is_corresponding | False |
| authorships[12].author.id | |
| authorships[12].author.orcid | |
| authorships[12].author.display_name | Tonia, Thomai |
| authorships[12].countries | DE |
| authorships[12].affiliations[0].institution_ids | https://openalex.org/I4210150406 |
| authorships[12].affiliations[0].raw_affiliation_string | Institut für Sozial- und Präventivmedizin (ISPM) - Evidence Synthesis Methods |
| authorships[12].institutions[0].id | https://openalex.org/I4210150406 |
| authorships[12].institutions[0].ror | https://ror.org/https://ror.org/04bhvak10 |
| authorships[12].institutions[0].type | nonprofit |
| authorships[12].institutions[0].lineage | https://openalex.org/I4210150406 |
| authorships[12].institutions[0].country_code | DE |
| authorships[12].institutions[0].display_name | Institut für Soziale Arbeit |
| authorships[12].author_position | middle |
| authorships[12].raw_author_name | Tonia, Thomai |
| authorships[12].is_corresponding | False |
| authorships[12].raw_affiliation_strings | Institut für Sozial- und Präventivmedizin (ISPM) - Evidence Synthesis Methods |
| authorships[13].author.id | |
| authorships[13].author.orcid | |
| authorships[13].author.display_name | Wheeler, Emily |
| authorships[13].author_position | middle |
| authorships[13].raw_author_name | Wheeler, Emily |
| authorships[13].is_corresponding | False |
| authorships[14].author.id | https://openalex.org/A4221473625 |
| authorships[14].author.orcid | |
| authorships[14].author.display_name | Furukawa, Toshi A. |
| authorships[14].author_position | middle |
| authorships[14].raw_author_name | Furukawa, Toshi A |
| authorships[14].is_corresponding | False |
| authorships[15].author.id | https://openalex.org/A4305568818 |
| authorships[15].author.orcid | |
| authorships[15].author.display_name | Pizzagalli, Diego A. |
| authorships[15].author_position | middle |
| authorships[15].raw_author_name | Pizzagalli, Diego A |
| authorships[15].is_corresponding | False |
| authorships[16].author.id | |
| authorships[16].author.orcid | |
| authorships[16].author.display_name | Browning, Michael |
| authorships[16].author_position | middle |
| authorships[16].raw_author_name | Browning, Michael |
| authorships[16].is_corresponding | False |
| authorships[17].author.id | https://openalex.org/A4284103829 |
| authorships[17].author.orcid | |
| authorships[17].author.display_name | Potts, Jennifer |
| authorships[17].author_position | middle |
| authorships[17].raw_author_name | Potts, Jennifer |
| authorships[17].is_corresponding | False |
| authorships[18].author.id | https://openalex.org/A2602700222 |
| authorships[18].author.orcid | |
| authorships[18].author.display_name | Cipriani Andrea |
| authorships[18].author_position | last |
| authorships[18].raw_author_name | Cipriani, Andrea |
| authorships[18].is_corresponding | False |
| has_content.pdf | False |
| has_content.grobid_xml | False |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://doi.org/10.48620/92289 |
| open_access.oa_status | green |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-11-11T00:00:00 |
| display_name | Pro-dopaminergic pharmacological interventions for anhedonia in depression: a living systematic review and network meta-analysis of human and animal studies. |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-11T23:23:10.385787 |
| primary_topic.id | https://openalex.org/T11071 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 0.20255331695079803 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2736 |
| primary_topic.subfield.display_name | Pharmacology |
| primary_topic.display_name | Treatment of Major Depression |
| cited_by_count | 0 |
| locations_count | 1 |
| best_oa_location.id | doi:10.48620/92289 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S7407053152 |
| best_oa_location.source.type | repository |
| best_oa_location.source.is_oa | False |
| best_oa_location.source.issn_l | |
| best_oa_location.source.is_core | False |
| best_oa_location.source.is_in_doaj | False |
| best_oa_location.source.display_name | Open Access CRIS of the University of Bern |
| best_oa_location.source.host_organization | |
| best_oa_location.source.host_organization_name | |
| best_oa_location.source.host_organization_lineage | |
| best_oa_location.license | |
| best_oa_location.pdf_url | |
| best_oa_location.version | |
| best_oa_location.raw_type | article-journal |
| best_oa_location.license_id | |
| best_oa_location.is_accepted | False |
| best_oa_location.is_published | False |
| best_oa_location.raw_source_name | |
| best_oa_location.landing_page_url | https://doi.org/10.48620/92289 |
| primary_location.id | doi:10.48620/92289 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S7407053152 |
| primary_location.source.type | repository |
| primary_location.source.is_oa | False |
| primary_location.source.issn_l | |
| primary_location.source.is_core | False |
| primary_location.source.is_in_doaj | False |
| primary_location.source.display_name | Open Access CRIS of the University of Bern |
| primary_location.source.host_organization | |
| primary_location.source.host_organization_name | |
| primary_location.source.host_organization_lineage | |
| primary_location.license | |
| primary_location.pdf_url | |
| primary_location.version | |
| primary_location.raw_type | article-journal |
| primary_location.license_id | |
| primary_location.is_accepted | False |
| primary_location.is_published | False |
| primary_location.raw_source_name | |
| primary_location.landing_page_url | https://doi.org/10.48620/92289 |
| publication_date | 2025-10-29 |
| publication_year | 2025 |
| referenced_works_count | 0 |
| abstract_inverted_index.= | 226 |
| abstract_inverted_index.A | 167 |
| abstract_inverted_index.a | 155, 185, 190, 217, 277 |
| abstract_inverted_index.n | 225 |
| abstract_inverted_index.(6 | 223 |
| abstract_inverted_index.(a | 90 |
| abstract_inverted_index.9, | 75 |
| abstract_inverted_index.CI | 231 |
| abstract_inverted_index.In | 270 |
| abstract_inverted_index.It | 1 |
| abstract_inverted_index.We | 101, 124, 134, 253 |
| abstract_inverted_index.as | 114, 266 |
| abstract_inverted_index.be | 332 |
| abstract_inverted_index.if | 16 |
| abstract_inverted_index.in | 9, 47, 52, 59, 84, 99, 145, 204, 235, 243, 261, 284, 310, 319 |
| abstract_inverted_index.is | 2, 22, 195 |
| abstract_inverted_index.of | 35, 44, 50, 92, 140, 157, 161, 170, 187, 197, 220, 280, 296, 308, 317, 342 |
| abstract_inverted_index.on | 148, 344, 349 |
| abstract_inverted_index.or | 338 |
| abstract_inverted_index.to | 18, 111, 233, 251, 268, 335, 358 |
| abstract_inverted_index.we | 29, 327 |
| abstract_inverted_index.(27 | 246 |
| abstract_inverted_index.95% | 230 |
| abstract_inverted_index.MDD | 55, 238 |
| abstract_inverted_index.Our | 300 |
| abstract_inverted_index.SMD | 228, 248 |
| abstract_inverted_index.The | 77 |
| abstract_inverted_index.and | 14, 58, 86, 95, 106, 121, 131, 150, 164, 183, 207, 239, 293, 326, 354, 366 |
| abstract_inverted_index.are | 322, 356 |
| abstract_inverted_index.did | 254 |
| abstract_inverted_index.for | 97, 129, 201, 305 |
| abstract_inverted_index.low | 267 |
| abstract_inverted_index.may | 331 |
| abstract_inverted_index.not | 255 |
| abstract_inverted_index.so, | 17 |
| abstract_inverted_index.the | 23, 41, 137, 180, 271, 306, 313, 361 |
| abstract_inverted_index.two | 31 |
| abstract_inverted_index.via | 189 |
| abstract_inverted_index.was | 264, 288 |
| abstract_inverted_index.0.88 | 250 |
| abstract_inverted_index.June | 74 |
| abstract_inverted_index.This | 193 |
| abstract_inverted_index.With | 25 |
| abstract_inverted_index.also | 135 |
| abstract_inverted_index.both | 162 |
| abstract_inverted_index.data | 257, 348 |
| abstract_inverted_index.find | 256 |
| abstract_inverted_index.list | 186 |
| abstract_inverted_index.more | 339 |
| abstract_inverted_index.part | 196 |
| abstract_inverted_index.role | 307 |
| abstract_inverted_index.some | 274, 303 |
| abstract_inverted_index.such | 113 |
| abstract_inverted_index.test | 89 |
| abstract_inverted_index.than | 290 |
| abstract_inverted_index.that | 329 |
| abstract_inverted_index.then | 178 |
| abstract_inverted_index.they | 330 |
| abstract_inverted_index.this | 21 |
| abstract_inverted_index.were | 71, 80, 214 |
| abstract_inverted_index.what | 19 |
| abstract_inverted_index.with | 54, 175, 216, 237, 276 |
| abstract_inverted_index.(MDD) | 13 |
| abstract_inverted_index.-0.46 | 232 |
| abstract_inverted_index.1.34, | 249 |
| abstract_inverted_index.2024. | 76 |
| abstract_inverted_index.2076; | 227 |
| abstract_inverted_index.RCTs, | 224 |
| abstract_inverted_index.RCTs; | 247 |
| abstract_inverted_index.about | 258 |
| abstract_inverted_index.data. | 166 |
| abstract_inverted_index.drugs | 6, 292 |
| abstract_inverted_index.human | 130, 146 |
| abstract_inverted_index.lived | 26, 176 |
| abstract_inverted_index.major | 10, 320 |
| abstract_inverted_index.other | 103 |
| abstract_inverted_index.panel | 169 |
| abstract_inverted_index.posit | 328 |
| abstract_inverted_index.proxy | 96 |
| abstract_inverted_index.rated | 265 |
| abstract_inverted_index.small | 218 |
| abstract_inverted_index.still | 323 |
| abstract_inverted_index.study | 194 |
| abstract_inverted_index.tasks | 260 |
| abstract_inverted_index.these | 345 |
| abstract_inverted_index.until | 73 |
| abstract_inverted_index.using | 154 |
| abstract_inverted_index.which | 287 |
| abstract_inverted_index.(RCTs) | 39 |
| abstract_inverted_index.-0.03) | 234 |
| abstract_inverted_index.-0.24, | 229 |
| abstract_inverted_index.1.79). | 252 |
| abstract_inverted_index.Living | 202 |
| abstract_inverted_index.action | 281 |
| abstract_inverted_index.animal | 62, 244 |
| abstract_inverted_index.extent | 20 |
| abstract_inverted_index.humans | 85 |
| abstract_inverted_index.larger | 289 |
| abstract_inverted_index.living | 32 |
| abstract_inverted_index.models | 63, 245 |
| abstract_inverted_index.needed | 357 |
| abstract_inverted_index.people | 53, 174, 236 |
| abstract_inverted_index.poorly | 324 |
| abstract_inverted_index.reduce | 7 |
| abstract_inverted_index.reward | 93 |
| abstract_inverted_index.series | 156 |
| abstract_inverted_index.showed | 282 |
| abstract_inverted_index.tasks, | 116 |
| abstract_inverted_index.trials | 38 |
| abstract_inverted_index.versus | 142 |
| abstract_inverted_index.(Global | 199 |
| abstract_inverted_index.(versus | 56, 64 |
| abstract_inverted_index.GALENOS | 198 |
| abstract_inverted_index.adverse | 122 |
| abstract_inverted_index.anxiety | 117 |
| abstract_inverted_index.aspects | 108 |
| abstract_inverted_index.between | 363 |
| abstract_inverted_index.closely | 109 |
| abstract_inverted_index.domains | 105 |
| abstract_inverted_index.effects | 139, 341 |
| abstract_inverted_index.events. | 123 |
| abstract_inverted_index.examine | 360 |
| abstract_inverted_index.experts | 28, 172 |
| abstract_inverted_index.general | 340 |
| abstract_inverted_index.humans. | 262 |
| abstract_inverted_index.measure | 91 |
| abstract_inverted_index.memory, | 355 |
| abstract_inverted_index.network | 159, 272 |
| abstract_inverted_index.overall | 151, 181, 297 |
| abstract_inverted_index.precise | 314 |
| abstract_inverted_index.primary | 78 |
| abstract_inverted_index.provide | 302 |
| abstract_inverted_index.related | 110, 334 |
| abstract_inverted_index.results | 182 |
| abstract_inverted_index.reviews | 34 |
| abstract_inverted_index.reward, | 350 |
| abstract_inverted_index.studies | 147 |
| abstract_inverted_index.sucrose | 87, 241 |
| abstract_inverted_index.support | 304 |
| abstract_inverted_index.unclear | 3 |
| abstract_inverted_index.vehicle | 65 |
| abstract_inverted_index.whether | 4 |
| abstract_inverted_index.(GALENOS | 369 |
| abstract_inverted_index.Alliance | 200 |
| abstract_inverted_index.Evidence | 203, 263 |
| abstract_inverted_index.However, | 312 |
| abstract_inverted_index.Multiple | 68 |
| abstract_inverted_index.PROSPERO | 209 |
| abstract_inverted_index.Wellcome | 368 |
| abstract_inverted_index.aNxiety, | 205 |
| abstract_inverted_index.animals. | 100 |
| abstract_inverted_index.clinical | 107 |
| abstract_inverted_index.disorder | 12 |
| abstract_inverted_index.dopamine | 309, 364 |
| abstract_inverted_index.efficacy | 43 |
| abstract_inverted_index.findings | 301 |
| abstract_inverted_index.further, | 15 |
| abstract_inverted_index.learning | 353 |
| abstract_inverted_index.outcomes | 79 |
| abstract_inverted_index.pairwise | 126 |
| abstract_inverted_index.placebo) | 57 |
| abstract_inverted_index.possibly | 333 |
| abstract_inverted_index.probably | 294 |
| abstract_inverted_index.process. | 192 |
| abstract_inverted_index.produced | 184 |
| abstract_inverted_index.properly | 359 |
| abstract_inverted_index.reducing | 48 |
| abstract_inverted_index.relative | 42, 138 |
| abstract_inverted_index.relevant | 60 |
| abstract_inverted_index.searched | 72 |
| abstract_inverted_index.studies. | 133 |
| abstract_inverted_index.symptoms | 49, 83, 153, 222 |
| abstract_inverted_index.aggregate | 163 |
| abstract_inverted_index.anhedonia | 8, 51, 82, 149, 221, 285, 318 |
| abstract_inverted_index.databases | 70 |
| abstract_inverted_index.different | 337 |
| abstract_inverted_index.estimated | 136 |
| abstract_inverted_index.evaluated | 102 |
| abstract_inverted_index.important | 104 |
| abstract_inverted_index.including | 351 |
| abstract_inverted_index.increased | 240 |
| abstract_inverted_index.mechanism | 279 |
| abstract_inverted_index.moderate. | 269 |
| abstract_inverted_index.non-human | 61, 132 |
| abstract_inverted_index.performed | 125 |
| abstract_inverted_index.project). | 370 |
| abstract_inverted_index.reduction | 219, 283 |
| abstract_inverted_index.symptoms, | 118, 286 |
| abstract_inverted_index.symptoms. | 346 |
| abstract_inverted_index.(including | 173 |
| abstract_inverted_index.Background | 0 |
| abstract_inverted_index.Therefore, | 347 |
| abstract_inverted_index.altogether | 336 |
| abstract_inverted_index.anhedonia) | 98 |
| abstract_inverted_index.anhedonia, | 112 |
| abstract_inverted_index.anhedonia. | 311 |
| abstract_inverted_index.associated | 215 |
| abstract_inverted_index.control/no | 66 |
| abstract_inverted_index.controlled | 37 |
| abstract_inverted_index.depression | 298, 321 |
| abstract_inverted_index.depressive | 11, 152 |
| abstract_inverted_index.electronic | 69 |
| abstract_inverted_index.mechanisms | 316 |
| abstract_inverted_index.modulation | 365 |
| abstract_inverted_index.preference | 88, 242 |
| abstract_inverted_index.randomised | 36 |
| abstract_inverted_index.separately | 128 |
| abstract_inverted_index.subjective | 81 |
| abstract_inverted_index.systematic | 33 |
| abstract_inverted_index.understood | 325 |
| abstract_inverted_index.co-produced | 30 |
| abstract_inverted_index.depressiOn, | 206 |
| abstract_inverted_index.experience) | 177 |
| abstract_inverted_index.experienced | 27 |
| abstract_inverted_index.independent | 295 |
| abstract_inverted_index.interpreted | 179 |
| abstract_inverted_index.pSychosis). | 208 |
| abstract_inverted_index.sensitivity | 94 |
| abstract_inverted_index.case.Methods | 24 |
| abstract_inverted_index.relationship | 362 |
| abstract_inverted_index.international | 171 |
| abstract_inverted_index.interventions | 46, 213 |
| abstract_inverted_index.investigating | 40 |
| abstract_inverted_index.meta-analyses | 127, 160 |
| abstract_inverted_index.patient-level | 165 |
| abstract_inverted_index.registration: | 210 |
| abstract_inverted_index.tolerability, | 120 |
| abstract_inverted_index.triangulation | 191 |
| abstract_inverted_index.acceptability, | 119 |
| abstract_inverted_index.intervention). | 67 |
| abstract_inverted_index.meta-analysis, | 273 |
| abstract_inverted_index.random-effects | 158 |
| abstract_inverted_index.reward-related | 352 |
| abstract_inverted_index.antidepressants | 144, 275, 343 |
| abstract_inverted_index.neurobiological | 315 |
| abstract_inverted_index.recommendations | 188 |
| abstract_inverted_index.Pro-dopaminergic | 212 |
| abstract_inverted_index.non-dopaminergic | 143, 278 |
| abstract_inverted_index.pro-dopaminergic | 5, 45, 141, 291 |
| abstract_inverted_index.anhedonia.Funding | 367 |
| abstract_inverted_index.multidisciplinary | 168 |
| abstract_inverted_index.reward/reinforcement | 115, 259 |
| abstract_inverted_index.CRD42023451821.Findings | 211 |
| abstract_inverted_index.improvement.Interpretation | 299 |
| cited_by_percentile_year | |
| countries_distinct_count | 1 |
| institutions_distinct_count | 19 |
| citation_normalized_percentile.value | 0.79721776 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |